{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "Amyotrophic lateral sclerosis", "Huntington disease", "Multiple myeloma", "Parkinson's disease", "neurodegenerative diseases", "polyphenols", "ubiquitin-proteasome pathway"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32411012", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "04", "Day": "28"}], "Language": ["eng"], "ELocationID": ["361", "10.3389/fphys.2020.00361"], "Journal": {"ISSN": "1664-042X", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in physiology", "ISOAbbreviation": "Front Physiol"}, "ArticleTitle": "Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.", "Pagination": {"StartPage": "361", "MedlinePgn": "361"}, "Abstract": {"AbstractText": ["Misfolded proteins are the main common feature of neurodegenerative diseases, thereby, normal proteostasis is an important mechanism to regulate the neural survival and the central nervous system functionality. The ubiquitin-proteasome system (UPS) is a non-lysosomal proteolytic pathway involved in numerous normal functions of the nervous system, modulation of neurotransmitter release, synaptic plasticity, and recycling of membrane receptors or degradation of damaged and regulatory intracellular proteins. Aberrant accumulation of intracellular ubiquitin-positive inclusions has been implicated to a variety of neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington disease (HD), Amyotrophic Lateral Sclerosis (ALS), and Multiple Myeloma (MM). Genetic mutation in deubiquitinating enzyme could disrupt UPS and results in destructive effects on neuron survival. To date, various agents were characterized with proteasome-inhibitory potential. Proteins of the ubiquitin-proteasome system, and in particular, E3 ubiquitin ligases, may be promising molecular targets for neurodegenerative drug discovery. Phytochemicals, specifically polyphenols (PPs), were reported to act as proteasome-inhibitors or may modulate the proteasome activity. PPs modify the UPS by means of accumulation of ubiquitinated proteins, suppression of neuronal apoptosis, reduction of neurotoxicity, and improvement of synaptic plasticity and transmission. This is the first comprehensive review on the effect of PPs on UPS. Here, we review the recent findings describing various aspects of UPS dysregulation in neurodegenerative disorders. This review attempts to summarize the latest reports on the neuroprotective properties involved in the proper functioning of natural polyphenolic compounds with implication for targeting ubiquitin-proteasome pathway in the neurodegenerative diseases. We highlight the evidence suggesting that polyphenolic compounds have a dose and disorder dependent effects in improving neurological dysfunctions, and so their mechanism of action could stimulate the UPS, induce the protein degradation or inhibit UPS and reduce protein degradation. Future studies should focus on molecular mechanisms by which PPs can interfere this complex regulatory system at specific stages of the disease development and progression."], "CopyrightInformation": "Copyright \u00a9 2020 Momtaz, Memariani, El-Senduny, Sanadgol, Golab, Katebi, Abdolghaffari, Farzaei and Abdollahi."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group, Universal Scientific Education and Research Network, Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Traditional Medicine and History of Medical Sciences Research Center, Health Research Center, Babol University of Medical Sciences, Babol, Iran."}], "LastName": "Memariani", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, Mansoura University, Mansoura, Egypt."}], "LastName": "El-Senduny", "ForeName": "Fardous F", "Initials": "FF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Sciences, University of Zabol, Zabol, Iran."}, {"Identifier": [], "Affiliation": "Department of Biomolecular Sciences, School of Pharmaceutical Sciences, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil."}], "LastName": "Sanadgol", "ForeName": "Nima", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Iran University of Medical Science, Tehran, Iran."}], "LastName": "Golab", "ForeName": "Fereshteh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, Faculty of Medicine, Hormozgan University of Medical Sciences, Hormozgan, Iran."}], "LastName": "Katebi", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group, Universal Scientific Education and Research Network, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}, {"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Abdollahi", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Systematic Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Physiol", "NlmUniqueID": "101549006", "ISSNLinking": "1664-042X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ahmadi M., Agah E., Nafissi S., Jaafari M. R., Harirchian M. H., Sarraf P., et al. . (2018). Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics 15, 430\u2013438. 10.1007/s13311-018-0606-7", "ArticleIdList": ["10.1007/s13311-018-0606-7", "PMC5935637", "29352425"]}, {"Citation": "Ahtoniemi T., Goldsteins G., Keksa-Goldsteine V., Malm T., Kanninen K., Salminen A., et al. . (2007). Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis. Mol. Pharmacol. 71, 30\u201337. 10.1124/mol.106.028415", "ArticleIdList": ["10.1124/mol.106.028415", "17008387"]}, {"Citation": "Aizawa M., Abe Y., Ito T., Handa H., Nawa H. (2011). mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain. Neurosci. Res. 69, 343\u2013347. 10.1016/j.neures.2010.12.019", "ArticleIdList": ["10.1016/j.neures.2010.12.019", "21241746"]}, {"Citation": "Akutsu M., Dikic I., Bremm A. (2016). Ubiquitin chain diversity at a glance. J. Cell Sci. 129, 875\u2013880. 10.1242/jcs.183954", "ArticleIdList": ["10.1242/jcs.183954", "26906419"]}, {"Citation": "Almeida C. G., Takahashi R. H., Gouras G. K. (2006). Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J. Neurosci. 26, 4277\u20134288. 10.1523/JNEUROSCI.5078-05.2006", "ArticleIdList": ["10.1523/JNEUROSCI.5078-05.2006", "PMC6673997", "16624948"]}, {"Citation": "Al-Shami A., Jhaver K. G., Vogel P., Wilkins C., Humphries J., Davis J. J., et al. . (2010). Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development. PLoS ONE 5:e13654. 10.1371/journal.pone.0013654", "ArticleIdList": ["10.1371/journal.pone.0013654", "PMC2965108", "21048919"]}, {"Citation": "Attal M., Harousseau J.-L., Stoppa A.-M., Sotto J.-J., Fuzibet J.-G., Rossi J.-F., et al. . (1996). A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N. Engl. J. Med. 335, 91\u201397. 10.1056/NEJM199607113350204", "ArticleIdList": ["10.1056/NEJM199607113350204", "8649495"]}, {"Citation": "Ayissi V. B., Ebrahimi A., Schluesenner H. (2014). Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol. Nutr. Food Res. 58, 22\u201332. 10.1002/mnfr.201300195", "ArticleIdList": ["10.1002/mnfr.201300195", "23881751"]}, {"Citation": "Babitha K., Shanmuga Sundaram R., Annapandian V., Abhirama B., Sudha M., Thiyagarajan T., et al. (2014). Natural products and its derived drugs for the treatment of neurodegenerative disorders: Alzheimer's disease\u2013a review. Br. Biomed. Bull. 2, 359\u2013370."}, {"Citation": "Bagli E., Goussia A., Moschos M. M., Agnantis N., Kitsos G. (2016). Natural compounds and neuroprotection: mechanisms of action and novel delivery systems. In Vivo 30, 535\u2013547.", "ArticleIdList": ["27566070"]}, {"Citation": "Banerjee K., Munshi S., Sen O., Pramanik V., Roy Mukherjee T., Chakrabarti S. (2014). Dopamine cytotoxicity involves both oxidative and nonoxidative pathways in SH-SY5Y cells: potential role of alpha-synuclein overexpression and proteasomal inhibition in the etiopathogenesis of Parkinson's disease. Parkinsons Dis. 2014:878935. 10.1155/2014/878935", "ArticleIdList": ["10.1155/2014/878935", "PMC3996320", "24804146"]}, {"Citation": "Baum L., Lam C. W., Cheung S. K., Kwok T., Lui V., Tsoh J., et al. . (2008). Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28, 110\u2013113. 10.1097/jcp.0b013e318160862c", "ArticleIdList": ["10.1097/jcp.0b013e318160862c", "18204357"]}, {"Citation": "Bendall H. H., Sikes M. L., Ballard D. W., Oltz E. M. (1999). An intact NF-\u03baB signaling pathway is required for maintenance of mature B cell subsets. Mol. Immunol. 36, 187\u2013195. 10.1016/s0161-5890(99)00031-0", "ArticleIdList": ["10.1016/s0161-5890(99)00031-0", "10403484"]}, {"Citation": "Bendotti C., Marino M., Cheroni C., Fontana E., Crippa V., Poletti A., et al. . (2012). Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog. Neurobiol. 97, 101\u2013126. 10.1016/j.pneurobio.2011.10.001", "ArticleIdList": ["10.1016/j.pneurobio.2011.10.001", "22033150"]}, {"Citation": "Bennett E. J., Shaler T. A., Woodman B., Ryu K.-Y., Zaitseva T. S., Becker C. H., et al. . (2007). Global changes to the ubiquitin system in Huntington's disease. Nature 448:704. 10.1038/nature06022", "ArticleIdList": ["10.1038/nature06022", "17687326"]}, {"Citation": "Bilguvar K., Tyagi N. K., Ozkara C., Tuysuz B., Bakircioglu M., Choi M., et al. . (2013). Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 110, 3489\u20133494. 10.1073/pnas.1222732110", "ArticleIdList": ["10.1073/pnas.1222732110", "PMC3587195", "23359680"]}, {"Citation": "Blackinton J. G., Anvret A., Beilina A., Olson L., Cookson M. R., Galter D. (2007). Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease. Brain. Res. 1184, 10\u201316. 10.1016/j.brainres.2007.09.056", "ArticleIdList": ["10.1016/j.brainres.2007.09.056", "17950257"]}, {"Citation": "Borodovsky A., Kessler B. M., Casagrande R., Overkleeft H. S., Wilkinson K. D., Ploegh H. L. (2001). A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J. 20, 5187\u20135196. 10.1093/emboj/20.18.5187", "ArticleIdList": ["10.1093/emboj/20.18.5187", "PMC125629", "11566882"]}, {"Citation": "Bosco D. A., Morfini G., Karabacak N. M., Song Y., Gros-Louis F., Pasinelli P., et al. . (2010). Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13:1396. 10.1038/nn.2660", "ArticleIdList": ["10.1038/nn.2660", "PMC2967729", "20953194"]}, {"Citation": "Braidy N., Jugder B.-E., Poljak A., Jayasena T., Mansour H., Mohammad Nabavi S., et al. . (2016). Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer's disease. Curr. Top Med. Chem. 16, 1951\u20131960. 10.2174/1568026616666160204121431", "ArticleIdList": ["10.2174/1568026616666160204121431", "26845555"]}, {"Citation": "Branquinho Andrade P., Grosso C., Valentao P., Bernardo J. (2016). Flavonoids in neurodegeneration: limitations and strategies to cross CNS barriers. Curr. Med. Chem. 23, 4151\u20134174. 10.2174/0929867323666160809094934", "ArticleIdList": ["10.2174/0929867323666160809094934", "27516197"]}, {"Citation": "Brewer J. W., Diehl J. A. (2000). PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc. Natl. Acad. Sci. U.S.A. 97, 12625\u201312630. 10.1073/pnas.220247197", "ArticleIdList": ["10.1073/pnas.220247197", "PMC18814", "11035797"]}, {"Citation": "Briggs R., Kennelly S. P., O'neill D. (2016). Drug treatments in Alzheimer's disease. Clin. Med. 16, 247\u2013253. 10.7861/clinmedicine.16-3-247", "ArticleIdList": ["10.7861/clinmedicine.16-3-247", "PMC5922703", "27251914"]}, {"Citation": "Brockman J. A., Scherer D. C., McKinsey T. A., Hall S. M., Qi X., Lee W. Y., et al. . (1995). Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell Biol. 15, 2809\u20132818. 10.1128/mcb.15.5.2809", "ArticleIdList": ["10.1128/mcb.15.5.2809", "PMC230512", "7739562"]}, {"Citation": "Budd Haeberlein S., O'Gorman J., Chiao P., Bussiere T., von Rosenstiel P., Tian Y., et al. . (2017). Clinical development of aducanumab, an anti-abeta human monoclonal antibody being investigated for the treatment of early Alzheimer's disease. J. Prev. Alzheimers Dis. 4, 255\u2013263. 10.14283/jpad.2017.39", "ArticleIdList": ["10.14283/jpad.2017.39", "29181491"]}, {"Citation": "Cai Z., Zeng W., Tao K., Lu F., Gao G., Yang Q. (2015). Myricitrin alleviates MPP(+)-induced mitochondrial dysfunction in a DJ-1-dependent manner in SN4741 cells. Biochem. Biophys. Res. Commun. 458, 227\u2013233. 10.1016/j.bbrc.2015.01.060", "ArticleIdList": ["10.1016/j.bbrc.2015.01.060", "25623535"]}, {"Citation": "Cao J., Zhong M. B., Toro C. A., Zhang L., Cai D. (2019). Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis. Neurosci. Lett. 703, 68\u201378. 10.1016/j.neulet.2019.03.016", "ArticleIdList": ["10.1016/j.neulet.2019.03.016", "PMC6760990", "30890471"]}, {"Citation": "Cao K., Zheng A., Xu J., Li H., Liu J., Peng Y., et al. . (2014). AMPK activation prevents prenatal stress-induced cognitive impairment: modulation of mitochondrial content and oxidative stress. Free Radic. Biol. Med. 75, 156\u2013166. 10.1016/j.freeradbiomed.2014.07.029", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.07.029", "25091899"]}, {"Citation": "Cecarini V., Bonfili L., Cuccioloni M., Mozzicafreddo M., Rossi G., Keller J. N., et al. . (2014). Wild type and mutant amyloid precursor proteins influence downstream effects of proteasome and autophagy inhibition. Biochim. Biophys. Acta 1842, 127\u2013134. 10.1016/j.bbadis.2013.11.002", "ArticleIdList": ["10.1016/j.bbadis.2013.11.002", "24215712"]}, {"Citation": "Chang T.-L., Chiang H.-Y., Shen J.-Y., Lin S.-W., Tsai P.-J. (2015). Phenolic compounds stage an interplay between the ubiquitin\u2013proteasome system and ubiquitin signal autophagic degradation for the ubiquitin-based cancer chemoprevention. J. Funct. Food 17, 857\u2013871. 10.1016/j.jff.2015.06.010", "ArticleIdList": ["10.1016/j.jff.2015.06.010"]}, {"Citation": "Chauhan D., Li G., Hideshima T., Podar K., Mitsiades C., Mitsiades N., et al. . (2003). JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J. Biol. Chem. 278, 17593\u201317596. 10.1074/jbc.C300076200", "ArticleIdList": ["10.1074/jbc.C300076200", "12665525"]}, {"Citation": "Chen D., Chen M. S., Cui Q. C., Yang H., Dou Q. P. (2007a). Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells. Front. Biosci. 12, 1935\u20131945. 10.2741/2199", "ArticleIdList": ["10.2741/2199", "17127432"]}, {"Citation": "Chen D., Landis-Piwowar K. R., Chen M. S., Dou Q. P. (2007b). Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Res. 9:R80. 10.1186/bcr1797", "ArticleIdList": ["10.1186/bcr1797", "PMC2246179", "18300387"]}, {"Citation": "Chen J. J., Ondo W. G., Dashtipour K., Swope D. M. (2012). Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin. Ther. 34, 1487\u20131504. 10.1016/j.clinthera.2012.06.010", "ArticleIdList": ["10.1016/j.clinthera.2012.06.010", "22749259"]}, {"Citation": "Chen L., Thiruchelvam M. J., Madura K., Richfield E. K. (2006). Proteasome dysfunction in aged human \u03b1-synuclein transgenic mice. Neurobiol. Dis. 23, 120\u2013126. 10.1016/j.nbd.2006.02.004", "ArticleIdList": ["10.1016/j.nbd.2006.02.004", "16713278"]}, {"Citation": "Cheroni C., Marino M., Tortarolo M., Veglianese P., de Biasi S., Fontana E., et al. . (2008). Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, 82\u201396. 10.1093/hmg/ddn319", "ArticleIdList": ["10.1093/hmg/ddn319", "PMC3298865", "18826962"]}, {"Citation": "Chico L., Ienco E. C., Bisordi C., Lo Gerfo A., Petrozzi L., Petrucci A., et al. . (2018). Amyotrophic lateral sclerosis and oxidative stress: a double-blind therapeutic trial after curcumin supplementation. CNS Neurol. Disord. Drug Targets 17, 767\u2013779. 10.2174/1871527317666180720162029", "ArticleIdList": ["10.2174/1871527317666180720162029", "30033879"]}, {"Citation": "Choudhary S., Kumar P., Malik J. (2013). Plants and phytochemicals for Huntington's disease. Pharmacogn. Rev. 7, 81\u201391. 10.4103/0973-7847.120505", "ArticleIdList": ["10.4103/0973-7847.120505", "PMC3841999", "24347915"]}, {"Citation": "Ciechanover A. (2005). Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell Biol. 6:79. 10.1038/nrm1552", "ArticleIdList": ["10.1038/nrm1552", "15688069"]}, {"Citation": "Clements C. M., McNally R. S., Conti B. J., Mak T. W., Ting J. P.-Y. (2006). DJ-1, a cancer-and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. U.S.A. 103, 15091\u201315096. 10.1073/pnas.0607260103", "ArticleIdList": ["10.1073/pnas.0607260103", "PMC1586179", "17015834"]}, {"Citation": "Cookson M. R., Bandmann O. (2010). Parkinson's disease: insights from pathways. Hum. Mol. Genet. 19, R21\u2013R27. 10.1093/hmg/ddq167", "ArticleIdList": ["10.1093/hmg/ddq167", "PMC2875048", "20421364"]}, {"Citation": "Crippa V., Sau D., Rusmini P., Boncoraglio A., Onesto E., Bolzoni E., et al. . (2010). The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum. Mol. Genet. 19, 3440\u20133456. 10.1093/hmg/ddq257", "ArticleIdList": ["10.1093/hmg/ddq257", "20570967"]}, {"Citation": "Cummins J. M., Rago C., Kohli M., Kinzler K. W., Lengauer C., Vogelstein B. (2004). Tumour suppression: disruption of HAUSP gene stabilizes. Nature 428, 1\u20132. 10.1038/nature02501", "ArticleIdList": ["10.1038/nature02501", "15058298"]}, {"Citation": "D'Angiolella V., Esencay M., Pagano M. (2013). A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis. Trends Cell Biol. 23, 135\u2013140. 10.1016/j.tcb.2012.10.011", "ArticleIdList": ["10.1016/j.tcb.2012.10.011", "PMC3597434", "23182110"]}, {"Citation": "Davinelli S., Sapere N., Visentin M., Zella D., Scapagnini G. (2013). Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cells. Immun. Ageing 10:28. 10.1186/1742-4933-10-28", "ArticleIdList": ["10.1186/1742-4933-10-28", "PMC3750512", "23842073"]}, {"Citation": "de la Torre R., de Sola S., Hernandez G., Farre M., Pujol J., Rodriguez J., et al. . (2016). Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 15, 801\u2013810. 10.1016/S1474-4422(16)30034-5", "ArticleIdList": ["10.1016/S1474-4422(16)30034-5", "27302362"]}, {"Citation": "de Oliveira M. R., Nabavi S. F., Habtemariam S., Erdogan Orhan I., Daglia M., Nabavi S. M. (2015). The effects of baicalein and baicalin on mitochondrial function and dynamics: a review. Pharmacol. Res. 100, 296\u2013308. 10.1016/j.phrs.2015.08.021", "ArticleIdList": ["10.1016/j.phrs.2015.08.021", "26318266"]}, {"Citation": "de Oliveira M. R., Nabavi S. F., Manayi A., Daglia M., Hajheydari Z., Nabavi S. M. (2016). Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochim. Biophys. Acta 1860, 727\u2013745. 10.1016/j.bbagen.2016.01.017", "ArticleIdList": ["10.1016/j.bbagen.2016.01.017", "26802309"]}, {"Citation": "de Rus Jacquet A., Tambe M. A., Rochet J. C. (2017a). Dietary phytochemicals in neurodegenerative disease, in Nutrition in the Prevention and Treatment of Disease, 4th ed eds Coulston A. M., Boushey C. J., Ferruzzi M. G., Delahanty L. M. (Elsevier; Academic Press; ), 361\u2013391. 10.1016/B978-0-12-802928-2.00018-7", "ArticleIdList": ["10.1016/B978-0-12-802928-2.00018-7"]}, {"Citation": "de Rus Jacquet A., Timmers M., Ma S. Y., Thieme A., McCabe G. P., Vest J. H. C., et al. . (2017b). Lumbee traditional medicine: neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms. J. Ethnopharmacol. 206, 408\u2013425. 10.1016/j.jep.2017.02.021", "ArticleIdList": ["10.1016/j.jep.2017.02.021", "PMC6149226", "28214539"]}, {"Citation": "del Rosario Campos-Esparza M., Adriana Torres-Ramos M. (2010). Neuroprotection by natural polyphenols: molecular mechanisms. Cent. Nerv. Syst. Agents Med. Chem. 10, 269\u2013277. 10.2174/187152410793429728", "ArticleIdList": ["10.2174/187152410793429728", "20868360"]}, {"Citation": "Deng H.-X., Chen W., Hong S.-T., Boycott K. M., Gorrie G. H., Siddique N., et al. . (2011). Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211\u2013215. 10.1038/nature10353", "ArticleIdList": ["10.1038/nature10353", "PMC3169705", "21857683"]}, {"Citation": "Deng H. X., Zhai H., Bigio E. H., Yan J., Fecto F., Ajroud K., et al. . (2010). FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 67, 739\u2013748. 10.1002/ana.22051", "ArticleIdList": ["10.1002/ana.22051", "PMC4376270", "20517935"]}, {"Citation": "Dennissen F., Kholod N., van Leeuwen F. (2012). The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim? Prog. Neurobiol. 96, 190\u2013207. 10.1016/j.pneurobio.2012.01.003", "ArticleIdList": ["10.1016/j.pneurobio.2012.01.003", "22270043"]}, {"Citation": "Devi K. P., Shanmuganathan B., Manayi A., Nabavi S. F., Nabavi S. M. (2017). Molecular and therapeutic targets of genistein in Alzheimer's disease. Mol. Neurobiol. 54, 7028\u20137041. 10.1007/s12035-016-0215-6", "ArticleIdList": ["10.1007/s12035-016-0215-6", "27796744"]}, {"Citation": "Dey A., De J. N. (2015). Neuroprotective therapeutics from botanicals and phytochemicals against Huntington's disease and related neurodegenerative disorders. J. Herb. Med. 5, 1\u201319. 10.1016/j.hermed.2015.01.002", "ArticleIdList": ["10.1016/j.hermed.2015.01.002"]}, {"Citation": "DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J., et al. . (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993. 10.1126/science.277.5334.1990", "ArticleIdList": ["10.1126/science.277.5334.1990", "9302293"]}, {"Citation": "Dil Kuazi A., Kito K., Abe Y., Shin R. W., Kamitani T., Ueda N. (2003). NEDD8 protein is involved in ubiquitinated inclusion bodies. J. Pathol. 199, 259\u2013266. 10.1002/path.1283", "ArticleIdList": ["10.1002/path.1283", "12533840"]}, {"Citation": "Ding Y., Chen X., Wang B., Yu B., Ge J., Shi X. (2018). Quercetin suppresses the chymotrypsin-like activity of proteasome via inhibition of MEK1/ERK1/2 signaling pathway in hepatocellular carcinoma HepG2 cells. Can. J. Physiol. Pharmacol. 96, 521\u2013526. 10.1139/cjpp-2017-0655", "ArticleIdList": ["10.1139/cjpp-2017-0655", "29394494"]}, {"Citation": "Dolan P. J., Johnson G. V. (2010). A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J. Biol. Chem. 110:110940 10.1074/jbc.M110.110940", "ArticleIdList": ["10.1074/jbc.M110.110940", "PMC2903354", "20466727"]}, {"Citation": "Dreiseitel A., Schreier P., Oehme A., Locher S., Rogler G., Piberger H., et al. . (2008). Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochem. Biophys. Res. Commun. 372, 57\u201361. 10.1016/j.bbrc.2008.04.140", "ArticleIdList": ["10.1016/j.bbrc.2008.04.140", "18460339"]}, {"Citation": "Ellgaard L., Molinari M., Helenius A. (1999). Setting the standards: quality control in the secretory pathway. Science 286, 1882\u20131888. 10.1126/science.286.5446.1882", "ArticleIdList": ["10.1126/science.286.5446.1882", "10583943"]}, {"Citation": "Esteras N., Mu\u00f1oz \u00da., Alqu\u00e9zar C., Bartolom\u00e9 F., Bermejo-Pareja F., Mart\u00edn-Requero \u00c1. (2012). Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients. Curr. Alzheimers Res. 9, 267\u2013277. 10.2174/156720512800107564", "ArticleIdList": ["10.2174/156720512800107564", "22044025"]}, {"Citation": "Everett R. D., Meredith M., Orr A., Cross A., Kathoria M., Parkinson J. (1997). A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16, 566\u2013577. 10.1093/emboj/16.3.566", "ArticleIdList": ["10.1093/emboj/16.3.566", "PMC1169660", "9034339"]}, {"Citation": "Farooqui T., Farooqui A. A. (2018). Neuroprotective effects of garlic in model systems of neurodegenerative diseases, in Role of the Mediterranean Diet in the Brain and Neurodegenerative Diseases, eds Farooqui T., Farooqui A. A. (Elsevier; Academic Press; ), 253\u2013269. 10.1016/B978-0-12-811959-4.00016-X", "ArticleIdList": ["10.1016/B978-0-12-811959-4.00016-X"]}, {"Citation": "Farzaei M. H., Shahpiri Z., Mehri M. R., Bahramsoltani R., Rezaei M., Raeesdana A., et al. . (2018a). Medicinal plants in neurodegenerative diseases: perspective of traditional persian medicine. Curr. Drug Metabol. 19, 429\u2013442. 10.2174/1389200219666180305150256", "ArticleIdList": ["10.2174/1389200219666180305150256", "29512453"]}, {"Citation": "Farzaei M. H., Tewari D., Momtaz S., Arg\u00fcelles S., Nabavi S. M. (2018b). Targeting ERK signaling pathway by polyphenols as novel therapeutic strategy for neurodegeneration. Food Chem. Toxicol. 120, 183\u2013195. 10.1016/j.fct.2018.07.010", "ArticleIdList": ["10.1016/j.fct.2018.07.010", "29981370"]}, {"Citation": "Filipits M., Pohl G., Stranzl T., Kaufmann H., Ackermann J., Gisslinger H., et al. . (2003). Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma. Clin. Cancer Res. 9, 820\u2013826.", "ArticleIdList": ["12576455"]}, {"Citation": "Fiorani M., Guidarelli A., Blasa M., Azzolini C., Candiracci M., Piatti E., et al. . (2010). Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J. Nutr. Biochem. 21, 397\u2013404. 10.1016/j.jnutbio.2009.01.014", "ArticleIdList": ["10.1016/j.jnutbio.2009.01.014", "19278846"]}, {"Citation": "Fischer E. S., B\u00f6hm K., Lydeard J. R., Yang H., Stadler M. B., Cavadini S., et al. . (2014). Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512, 49. 10.1038/nature13527", "ArticleIdList": ["10.1038/nature13527", "PMC4423819", "25043012"]}, {"Citation": "Freemont P. S. (2000). Ubiquitination: RING for destruction? Curr. Biol. 10, R84\u2013R87. 10.1016/S0960-9822(00)00287-6", "ArticleIdList": ["10.1016/S0960-9822(00)00287-6", "10662664"]}, {"Citation": "Giacoppo S., Galuppo M., Montaut S., Iori R., Rollin P., Bramanti P., et al. . (2015). An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases. Fitoterapia 106, 12\u201321. 10.1016/j.fitote.2015.08.001", "ArticleIdList": ["10.1016/j.fitote.2015.08.001", "26254971"]}, {"Citation": "Giguere N., Pacelli C., Saumure C., Bourque M.-J., Matheoud D., Levesque D., et al. (2018). Comparative analysis of Parkinson's disease\u2013associated genes reveals altered survival and bioenergetics of parkin-deficient dopamine neurons in mice. J. Biol. Chem. 117:000499 10.1074/jbc.RA117.000499", "ArticleIdList": ["10.1074/jbc.RA117.000499", "PMC6016451", "29700116"]}, {"Citation": "Gleason C. E., Fischer B. L., Dowling N. M., Setchell K. D. R., Atwood C. S., Carlsson C. M., et al. . (2015). Cognitive effects of soy isoflavones in patients with Alzheimer's disease. J. Alzheimers Dis. 47, 1009\u20131019. 10.3233/JAD-142958", "ArticleIdList": ["10.3233/JAD-142958", "PMC4657545", "26401779"]}, {"Citation": "Gong B., Cao Z., Zheng P., Vitolo O. V., Liu S., Staniszewski A., et al. . (2006). Ubiquitin hydrolase Uch-L1 rescues \u03b2-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775\u2013788. 10.1016/j.cell.2006.06.046", "ArticleIdList": ["10.1016/j.cell.2006.06.046", "16923396"]}, {"Citation": "Gorji N., Moeini R., Memariani Z. (2018). Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer's disease: a neuropharmacological review of their bioactive constituents. Pharmacol. Res. 129, 115\u2013127. 10.1016/j.phrs.2017.12.003", "ArticleIdList": ["10.1016/j.phrs.2017.12.003", "29208493"]}, {"Citation": "Grice G. L., Nathan J. A. (2016). The recognition of ubiquitinated proteins by the proteasome. Cell Mol. Life Sci. 73, 3497\u20133506. 10.1007/s00018-016-2255-5", "ArticleIdList": ["10.1007/s00018-016-2255-5", "PMC4980412", "27137187"]}, {"Citation": "Grune T., Botzen D., Engels M., Voss P., Kaiser B., Jung T., et al. . (2010). Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions. Arch. Biochem. Biophys. 500, 181\u2013188. 10.1016/j.abb.2010.05.008", "ArticleIdList": ["10.1016/j.abb.2010.05.008", "PMC2904402", "20478262"]}, {"Citation": "Gu P. S., Moon M., Choi J. G., Oh M. S. (2017). Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing \u03b1-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/probenecid model. J. Nutr. Biochem. 39, 15\u201321. 10.1016/j.jnutbio.2016.08.014", "ArticleIdList": ["10.1016/j.jnutbio.2016.08.014", "27741433"]}, {"Citation": "Haass C., Selkoe D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid \u03b2-peptide. Nat. Rev. Mol. Cell Biol. 8:101. 10.1038/nrm2101", "ArticleIdList": ["10.1038/nrm2101", "17245412"]}, {"Citation": "Hajieva P. (2017). The effect of polyphenols on protein degradation pathways: implications for neuroprotection. Molecules 22:159. 10.3390/molecules22010159", "ArticleIdList": ["10.3390/molecules22010159", "PMC6155800", "28106854"]}, {"Citation": "Hardiman O., van den Berg L. H., Kiernan M. C. (2011). Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7:639. 10.1038/nrneurol.2011.153", "ArticleIdList": ["10.1038/nrneurol.2011.153", "21989247"]}, {"Citation": "Hasan W., Kori R. K., Jain J., Yadav R. S., Jat D. (2019b). Neuroprotective effects of mitochondria-targeted curcumin against rotenone-induced oxidative damage in cerebellum of mice. J. Biochem. Mol. Toxicol. 34:e22416. 10.1002/jbt.22416", "ArticleIdList": ["10.1002/jbt.22416", "31714633"]}, {"Citation": "Hasan W., Kori R. K., Thakre K., Yadav R. S., Jat D. (2019a). Synthesis, characterization and efficacy of mitochondrial targeted delivery of TPP-curcumin in rotenone-induced toxicity. DARU J. Pharm. Sci. 27, 557\u2013570. 10.1007/s40199-019-00283-2", "ArticleIdList": ["10.1007/s40199-019-00283-2", "PMC6895339", "31264184"]}, {"Citation": "Heeman B., van den Haute C., Aelvoet S. -A., Valsecchi F., Rodenburg R. J., Reumers V., et al. . (2011). Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J. Cell Sci. 124, 1115\u20131125. 10.1242/jcs.078303.", "ArticleIdList": ["10.1242/jcs.078303", "21385841"]}, {"Citation": "Hegde A. N., van Leeuwen F. W. (2017). Ubiquitin and the brain: roles of proteolysis in the normal and abnormal nervous system. Front. Mol. Neurosci. 10:220. 10.3389/fnmol.2017.00220", "ArticleIdList": ["10.3389/fnmol.2017.00220", "PMC5513962", "28769757"]}, {"Citation": "Hernandez F., Avila J. (2007). Tauopathies. Cell Mol. Life Sci. 64, 2219\u20132233. 10.1007/s00018-007-7220-x", "ArticleIdList": ["10.1007/s00018-007-7220-x", "17604998"]}, {"Citation": "Hideshima T., Richardson P., Chauhan D., Palombella V. J., Elliott P. J., Adams J., et al. . (2001). The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 61, 3071\u20133076.", "ArticleIdList": ["11306489"]}, {"Citation": "Higgins J. J., Hao J., Kosofsky B. E., Rajadhyaksha A. M. (2008). Dysregulation of large-conductance Ca 2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p. R419X mutation. Neurogenetics 9, 219\u2013223. 10.1007/s10048-008-0128-2", "ArticleIdList": ["10.1007/s10048-008-0128-2", "18414909"]}, {"Citation": "Higgins J. J., Tal A. L., Sun X., Hauck S. C., Hao J., Kosofosky B. E., et al. . (2010). Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence. J. Neurogenet. 24, 18\u201326. 10.3109/01677060903567849", "ArticleIdList": ["10.3109/01677060903567849", "20131966"]}, {"Citation": "Hiramatsu Y., Kitagawa K., Suzuki T., Uchida C., Hattori T., Kikuchi H., et al. . (2006). Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res. 66, 8477\u20138483. 10.1158/0008-5472.CAN-06-1603", "ArticleIdList": ["10.1158/0008-5472.CAN-06-1603", "16951159"]}, {"Citation": "Hohberger B., Enz R. (2009). Cereblon is expressed in the retina and binds to voltage-gated chloride channels. FEBS Lett. 583, 633\u2013637. 10.1016/j.febslet.2009.01.018", "ArticleIdList": ["10.1016/j.febslet.2009.01.018", "19166841"]}, {"Citation": "Houde C., Li Y., Song L., Barton K., Zhang Q., Godwin J., et al. . (2004). Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 104, 3697\u20133704. 10.1182/blood-2003-12-4114", "ArticleIdList": ["10.1182/blood-2003-12-4114", "15292061"]}, {"Citation": "Hu M., Li P., Li M., Li W., Yao T., Wu J.-W., et al. . (2002). Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041\u20131054. 10.1016/s0092-8674(02)01199-6", "ArticleIdList": ["10.1016/s0092-8674(02)01199-6", "12507430"]}, {"Citation": "Hu S., Maiti P., Ma Q., Zuo X., Jones M. R., Cole G. M., et al. . (2015). Clinical development of curcumin in neurodegenerative disease. Expert. Rev. Neurother. 15, 629\u2013637. 10.1586/14737175.2015.1044981", "ArticleIdList": ["10.1586/14737175.2015.1044981", "PMC6800094", "26035622"]}, {"Citation": "Huang H., Regan K. M., Wang F., Wang D., Smith D. I., van Deursen J. M., et al. . (2005). Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. U.S.A. 102, 1649\u20131654. 10.1073/pnas.0406789102", "ArticleIdList": ["10.1073/pnas.0406789102", "PMC545492", "15668399"]}, {"Citation": "Hyttinen J. M., Amadio M., Viiri J., Pascale A., Salminen A., Kaarniranta K. (2014). Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases. Ageing Res. Rev. 18, 16\u201328. 10.1016/j.arr.2014.07.002", "ArticleIdList": ["10.1016/j.arr.2014.07.002", "25062811"]}, {"Citation": "Ibba M., S\u00f6ll D. (1999). Quality control mechanisms during translation. Science 286, 1893\u20131897. 10.1126/science.286.5446.1893", "ArticleIdList": ["10.1126/science.286.5446.1893", "10583945"]}, {"Citation": "Ip P., Sharda P. R., Cunningham A., Chakrabartty S., Pande V., Chakrabartty A. (2017). Quercitrin and quercetin 3-\u03b2-d-glucoside as chemical chaperones for the A4V SOD1 ALS-causing mutant. Protein Eng. Des. Sel. 30, 431\u2013440. 10.1093/protein/gzx025", "ArticleIdList": ["10.1093/protein/gzx025", "PMC5939853", "28475686"]}, {"Citation": "Ito T., Ando H., Suzuki T., Ogura T., Hotta K., Imamura Y., et al. . (2010). Identification of a primary target of thalidomide teratogenicity. Science 327, 1345\u20131350. 10.1126/science.1177319", "ArticleIdList": ["10.1126/science.1177319", "20223979"]}, {"Citation": "Jaiswal M. K. (2018). Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med. Res. Rev. 39, 733\u2013748. 10.1002/med.21528", "ArticleIdList": ["10.1002/med.21528", "30101496"]}, {"Citation": "Jakob C., Egerer K., Liebisch P., T\u00fcrkmen S., Zavrski I., Kuckelkorn U., et al. . (2007). Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood 109, 2100\u20132105. 10.1182/blood-2006-04-016360", "ArticleIdList": ["10.1182/blood-2006-04-016360", "17095627"]}, {"Citation": "Jana N. R., Dikshit P., Goswami A., Nukina N. (2004). Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J. Biol. Chem. 279, 11680\u201311685. 10.1074/jbc.M310369200", "ArticleIdList": ["10.1074/jbc.M310369200", "14701837"]}, {"Citation": "Jankovic J., Poewe W. (2012). Therapies in Parkinson's disease. Curr. Opin. Neurol. 25, 433\u2013447. 10.1097/WCO.0b013e3283542fc2", "ArticleIdList": ["10.1097/WCO.0b013e3283542fc2", "22691758"]}, {"Citation": "Jara J. H., Frank D. D., \u00d6zdinler P.H. (2013). Could dysregulation of UPS be a common underlying mechanism for cancer and neurodegeneration? Lessons from UCHL1. Cell Biochem. Biophys. 67, 45\u201353. 10.1007/s12013-013-9631-7", "ArticleIdList": ["10.1007/s12013-013-9631-7", "23695785"]}, {"Citation": "Jo S., Lee K. H., Song S., Jung Y. K., Park C. S. (2005). Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain. J. Neurochem. 94, 1212\u20131224. 10.1111/j.1471-4159.2005.03344.x", "ArticleIdList": ["10.1111/j.1471-4159.2005.03344.x", "16045448"]}, {"Citation": "Johnson J. O., Mandrioli J., Benatar M., Abramzon Y., van Deerlin V. M., Trojanowski J. Q., et al. . (2010). Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857\u2013864. 10.1016/j.neuron.2010.11.036", "ArticleIdList": ["10.1016/j.neuron.2010.11.036", "PMC3032425", "21145000"]}, {"Citation": "Joshi V., Mishra R., Upadhyay A., Amanullah A., Poluri K. M., Singh S., et al. . (2019). Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: eliminates neurodegenerative proteins aggregation. J. Cell Physiol. 234, 20900\u201320914. 10.1002/jcp.28695", "ArticleIdList": ["10.1002/jcp.28695", "31004355"]}, {"Citation": "Jundt F., Probsting K. S., Anagnostopoulos I., Muehlinghaus G., Chatterjee M., Mathas S., et al. . (2004). Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood 103, 3511\u20133515. 10.1182/blood-2003-07-2254", "ArticleIdList": ["10.1182/blood-2003-07-2254", "14726396"]}, {"Citation": "Kabashi E., Agar J. N., Taylor D. M., Minotti S., Durham H. D. (2004). Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 89, 1325\u20131335. 10.1111/j.1471-4159.2004.02453.x", "ArticleIdList": ["10.1111/j.1471-4159.2004.02453.x", "15189335"]}, {"Citation": "Kabashi E., Valdmanis P. N., Dion P., Spiegelman D., McConkey B. J., Velde C. V., et al. . (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572\u2013574. 10.1038/ng.132", "ArticleIdList": ["10.1038/ng.132", "18372902"]}, {"Citation": "Kalchman M. A., Graham R. K., Xia G., Koide H. B., Hodgson J. G., Graham K. C., et al. . (1996). Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J. Biol. Chem. 271, 19385\u201319394. 10.1074/jbc.271.32.19385", "ArticleIdList": ["10.1074/jbc.271.32.19385", "8702625"]}, {"Citation": "Kamura T., Hara T., Kotoshiba S., Yada M., Ishida N., Imaki H., et al. . (2003). Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. Natl. Acad. Sci. U.S.A. 100, 10231\u201310236. 10.1073/pnas.1831009100", "ArticleIdList": ["10.1073/pnas.1831009100", "PMC193544", "12925736"]}, {"Citation": "Kaur R., Mehan S., Singh S. (2018). Understanding multifactorial architecture of Parkinson's disease: pathophysiology to management. Neurol. Sci. 40, 13\u201323. 10.1007/s10072-018-3585-x", "ArticleIdList": ["10.1007/s10072-018-3585-x", "30267336"]}, {"Citation": "Kazi A., Daniel K. G., Smith D. M., Kumar N. B., Dou Q. P. (2003). Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem. Pharmacol. 66, 965\u2013976. 10.1016/s1097-2765(03)00173-4", "ArticleIdList": ["10.1016/s1097-2765(03)00173-4", "12963483"]}, {"Citation": "Khasnavis S., Pahan K. (2014). Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease. J. Neuroimmune Pharm. 9, 569\u2013581. 10.1007/s11481-014-9552-2", "ArticleIdList": ["10.1007/s11481-014-9552-2", "PMC4167597", "24946862"]}, {"Citation": "Kim S. H., Shi Y., Hanson K. A., Williams L. M., Sakasai R., Bowler M. J., et al. . (2009). Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. J. Biol. Chem. 284, 8083\u20138092. 10.1074/jbc.M808064200", "ArticleIdList": ["10.1074/jbc.M808064200", "PMC2658102", "19112176"]}, {"Citation": "Kim S. Y., Herbst A., Tworkowski K. A., Salghetti S. E., Tansey W. P. (2003). Skp2 regulates Myc protein stability and activity. Mol. Cell 11, 1177\u20131188. 10.1016/S1097-2765(03)00173-4", "ArticleIdList": ["10.1016/S1097-2765(03)00173-4", "12769843"]}, {"Citation": "Kitada T., Pisani A., Porter D. R., Yamaguchi H., Tscherter A., Martella G., et al. . (2007). Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 104, 11441\u201311446. 10.1073/pnas.0702717104", "ArticleIdList": ["10.1073/pnas.0702717104", "PMC1890561", "17563363"]}, {"Citation": "Kitada T., Tong Y., Gautier C. A., Shen J. (2009). Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice. J. Neurochem. 111, 696\u2013702. 10.1111/j.1471-4159.2009.06350.x", "ArticleIdList": ["10.1111/j.1471-4159.2009.06350.x", "PMC2952933", "19694908"]}, {"Citation": "Klein U., Casola S., Cattoretti G., Shen Q., Lia M., Mo T., et al. . (2006). Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7, 773\u2013782. 10.1038/ni1357", "ArticleIdList": ["10.1038/ni1357", "16767092"]}, {"Citation": "Koh S.-H., Lee S. M., Kim H. Y., Lee K.-Y., Lee Y. J., Kim H.-T., et al. . (2006). The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 395, 103\u2013107. 10.1016/j.neulet.2005.10.056", "ArticleIdList": ["10.1016/j.neulet.2005.10.056", "16356650"]}, {"Citation": "Kr\u00f6nke J., Udeshi N. D., Narla A., Grauman P., Hurst S. N., McConkey M., et al. . (2013). Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301\u2013305. 10.1126/science.1244851", "ArticleIdList": ["10.1126/science.1244851", "PMC4077049", "24292625"]}, {"Citation": "Kumar P., Pradhan K., Karunya R., Ambasta R. K., Querfurth H. W. (2012). Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders. J. Neurochem. 120, 350\u2013370. 10.1111/j.1471-4159.2011.07588.x", "ArticleIdList": ["10.1111/j.1471-4159.2011.07588.x", "22098618"]}, {"Citation": "Kumar V. (2006). Potential medicinal plants for CNS disorders: an overview. Phytother. Res. 20, 1023\u20131035. 10.1002/ptr.1970", "ArticleIdList": ["10.1002/ptr.1970", "16909441"]}, {"Citation": "Kwak M.-K., Wakabayashi N., Greenlaw J. L., Yamamoto M., Kensler T. W. (2003). Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell Biol. 23, 8786\u20138794. 10.1128/mcb.23.23.8786-8794.2003", "ArticleIdList": ["10.1128/mcb.23.23.8786-8794.2003", "PMC262680", "14612418"]}, {"Citation": "Kwiatkowski T. J., Bosco D., Leclerc A., Tamrazian E., Vanderburg C., Russ C., et al. . (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205\u20131208. 10.1126/science.1166066", "ArticleIdList": ["10.1126/science.1166066", "19251627"]}, {"Citation": "Lee B.-H., Lee M. J., Park S., Oh D.-C., Elsasser S., Chen P.-C., et al. . (2010). Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179\u2013184. 10.1038/nature09299", "ArticleIdList": ["10.1038/nature09299", "PMC2939003", "20829789"]}, {"Citation": "Lee K. M., Jo S., Kim H., Lee J., Park C.-S. (2011). Functional modulation of AMP-activated protein kinase by cereblon. Biochim. Biophys. Acta Mol. Cell Res. 1813, 448\u2013455. 10.1016/j.bbamcr.2011.01.005", "ArticleIdList": ["10.1016/j.bbamcr.2011.01.005", "21232561"]}, {"Citation": "Lee M. J., Lee J. H., Rubinsztein D. C. (2013). Tau degradation: the ubiquitin\u2013proteasome system versus the autophagy-lysosome system. Prog. Neurobiol. 105, 49\u201359. 10.1016/j.pneurobio.2013.03.001", "ArticleIdList": ["10.1016/j.pneurobio.2013.03.001", "23528736"]}, {"Citation": "Leestemaker Y., Ovaa H. (2017). Tools to investigate the ubiquitin proteasome system. Drug Discov. Today Technol. 26, 25\u201331. 10.1016/j.ddtec.2017.11.006", "ArticleIdList": ["10.1016/j.ddtec.2017.11.006", "29249239"]}, {"Citation": "Leigh P., Whitwell H., Garofalo O., Buller J., Swash M., Martin J., et al. . (1991). Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: morphology, distribution, and specificity. Brain 114, 775\u2013788. 10.1093/brain/114.2.775", "ArticleIdList": ["10.1093/brain/114.2.775", "1646064"]}, {"Citation": "Li M., Brooks C. L., Kon N., Gu W. (2004). A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879\u2013886. 10.1016/s1097-2765(04)00157-1", "ArticleIdList": ["10.1016/s1097-2765(04)00157-1", "15053880"]}, {"Citation": "Li T., Feng Y., Yang R., Wu L., Li R., Huang L., et al. . (2018). Salidroside promotes the pathological \u03b1-synuclein clearance through ubiquitin-proteasome system in SH-SY5Y cells. Front. Pharmacol. 9:377. 10.3389/fphar.2018.00377", "ArticleIdList": ["10.3389/fphar.2018.00377", "PMC5917065", "29725300"]}, {"Citation": "Li X., Zhou J., Chen H., Wang F., Mei Q., Sun H. (2017). The association between the UBQLN1 polymorphism and Alzheimer's disease risk: a systematic review. Cell Mol. Biol. 63, 94\u201396. 10.14715/cmb/2017.63.5.17", "ArticleIdList": ["10.14715/cmb/2017.63.5.17", "28719358"]}, {"Citation": "Lim K.-L., Dawson V. L., Dawson T. M. (2006). Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases? Neurobiol. Aging 27, 524\u2013529. 10.1016/j.neurobiolaging.2005.07.023", "ArticleIdList": ["10.1016/j.neurobiolaging.2005.07.023", "16213628"]}, {"Citation": "Lin C. W., Wu M. J., Liu I. Y., Su J. D., Yen J. H. (2010). Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERK dependent induction of Nrf2-driven HO-1 expression. J. Agric. Food Chem. 58, 4477\u20134486 10.1021/jf904061x", "ArticleIdList": ["10.1021/jf904061x", "20302373"]}, {"Citation": "Liu J., Shaik S., Dai X., Wu Q., Zhou X., Wang Z., et al. . (2015). Targeting the ubiquitin pathway for cancer treatment. Biochim. Biophys. Acta Rev. Cancer 1855, 50\u201360. 10.1016/j.bbcan.2014.11.005", "ArticleIdList": ["10.1016/j.bbcan.2014.11.005", "PMC4312704", "25481052"]}, {"Citation": "Liu W., Vives-Bauza C., Yamamoto A., Tan Y., Li Y., Magran\u00e9 J., et al. . (2009). PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and \u03b1-synuclein aggregation in cell culture models of Parkinson's disease. PLoS ONE 4:e4597. 10.1371/journal.pone.0004597", "ArticleIdList": ["10.1371/journal.pone.0004597", "PMC2644779", "19242547"]}, {"Citation": "Liu Y., Hettinger C. L., Zhang D., Rezvani K., Wang X., Wang H. (2014). The proteasome function reporter GFPu accumulates in young brains of the APPswe/PS1dE9 Alzheimer's disease mouse model. Cell Prog. Neurobiol. 34, 315\u2013322. 10.1007/s10571-013-0022-9", "ArticleIdList": ["10.1007/s10571-013-0022-9", "PMC3954921", "24363091"]}, {"Citation": "Lobo V., Patil A., Phatak A., Chandra N. (2010). Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn. Rev. 4, 118\u2013126. 10.4103/0973-7847.70902", "ArticleIdList": ["10.4103/0973-7847.70902", "PMC3249911", "22228951"]}, {"Citation": "Logroscino G., Traynor B. J., Hardiman O., Chi\u00f2 A., Mitchell D., Swingler R. J., et al. . (2010). Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry 81:385\u2013390. 10.1136/jnnp.2009.183525", "ArticleIdList": ["10.1136/jnnp.2009.183525", "PMC2850819", "19710046"]}, {"Citation": "Lorenc-Koci E., Lenda T., Antkiewicz-Michaluk L., Wardas J., Domin H., Smia\u0142owska M., et al. . (2011). Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats. Neurochem. Int. 58, 839\u2013849. 10.1016/j.neuint.2011.03.013", "ArticleIdList": ["10.1016/j.neuint.2011.03.013", "21419185"]}, {"Citation": "Lunati A., Lesage S., Brice A. (2018). The genetic landscape of Parkinson's disease. Rev. Neurol. 174, 628\u2013643. 10.1016/j.neurol.2018.08.004", "ArticleIdList": ["10.1016/j.neurol.2018.08.004", "30245141"]}, {"Citation": "Ma M. H., Yang H. H., Parker K., Manyak S., Friedman J. M., Altamirano C., et al. . (2003). The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents. Clin. Cancer Res. 9, 1136\u20131144.", "ArticleIdList": ["12631619"]}, {"Citation": "Manavalan A., Mishra M., Feng L., Sze S. K., Akatsu H., Heese K. (2013). Brain site-specific proteome changes in aging-related dementia. Exp. Mol. Med. 45:e39. 10.1038/emm.2013.76", "ArticleIdList": ["10.1038/emm.2013.76", "PMC3789264", "24008896"]}, {"Citation": "Mandel S. A., Amit T., Weinreb O., Youdim M. B. (2011). Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases. J. Alzheimers Dis. 25, 187\u2013208. 10.3233/JAD-2011-101803", "ArticleIdList": ["10.3233/JAD-2011-101803", "21368374"]}, {"Citation": "Marambaud P., Zhao H., Davies P. (2005). Resveratrol promotes clearance of Alzheimer's disease amyloid-\u03b2 peptides J. Biol. Chem. 280, 37377\u201337382. 10.1074/jbc.M508246200", "ArticleIdList": ["10.1074/jbc.M508246200", "16162502"]}, {"Citation": "Martin D. D., Ladha S., Ehrnhoefer D. E., Hayden M. R. (2015). Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 38, 26\u201335. 10.1016/j.tins.2014.09.003", "ArticleIdList": ["10.1016/j.tins.2014.09.003", "25282404"]}, {"Citation": "Martin L., Latypova X., Terro F. (2011). Post-translational modifications of tau protein: implications for Alzheimer's disease. Neurochem. Int. 58, 458\u2013471. 10.1016/j.neuint.2010.12.023", "ArticleIdList": ["10.1016/j.neuint.2010.12.023", "21215781"]}, {"Citation": "Mart\u00ednez-Hu\u00e9lamo M., Rodr\u00edguez-Morat\u00f3 J., Boronat A., de la Torre R. (2017). Modulation of Nrf2 by olive oil and wine polyphenols and neuroprotection. Antioxidants 6:73. 10.3390/antiox6040073", "ArticleIdList": ["10.3390/antiox6040073", "PMC5745483", "28954417"]}, {"Citation": "Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., et al. . (2010). Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223. 10.1038/nature08971", "ArticleIdList": ["10.1038/nature08971", "20428114"]}, {"Citation": "Massey L. K., Mah A. L., Ford D. L., Miller J., Liang J., Doong H., et al. . (2004). Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. J. Alzheimers Dis. 6, 79\u201392. 10.3233/jad-2004-6109", "ArticleIdList": ["10.3233/jad-2004-6109", "15004330"]}, {"Citation": "Minati L., Edginton T., Grazia Bruzzone M., Giaccone G. (2009). Reviews: current concepts in Alzheimer's disease: a multidisciplinary review. Am. J. Alzheimers Dis. Other Dement. 24, 95\u2013121. 10.1177/1533317508328602", "ArticleIdList": ["10.1177/1533317508328602", "PMC10846154", "19116299"]}, {"Citation": "Mines M. A., Goodwin J. S., Limbird L. E., Cui F.-F., Fan G.-H. (2009). Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK activation. J. Biol. Chem. 284, 5742\u20135752. 10.1074/jbc.M808507200", "ArticleIdList": ["10.1074/jbc.M808507200", "PMC2645827", "19106094"]}, {"Citation": "Mitsiades N., Mitsiades C. S., Poulaki V., Chauhan D., Richardson P. G., Hideshima T., et al. . (2002). Biologic sequelae of nuclear factor\u2013\u03baB blockade in multiple myeloma: therapeutic applications. Blood 99, 4079\u20134086. 10.1182/blood.v99.11.4079", "ArticleIdList": ["10.1182/blood.v99.11.4079", "12010810"]}, {"Citation": "Mittr\u00fccker H.-W., Matsuyama T., Grossman A., K\u00fcndig T. M., Potter J., Shahinian A., et al. . (1997). Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540\u2013543. 10.1126/science.275.5299.540", "ArticleIdList": ["10.1126/science.275.5299.540", "8999800"]}, {"Citation": "Moosavi F., Hosseini R., Saso L., Firuzi O. (2016). Modulation of neurotrophic signaling pathways by polyphenols. Drug Des. Dev. Ther. 10, 23\u201342. 10.2147/DDDT.S96936", "ArticleIdList": ["10.2147/DDDT.S96936", "PMC4694682", "26730179"]}, {"Citation": "Morawe T., Hiebel C., Kern A., Behl C. (2012). Protein homeostasis, aging and Alzheimer's disease. Mol. Neurobiol. 46, 41\u201354. 10.1007/s12035-012-8246-0", "ArticleIdList": ["10.1007/s12035-012-8246-0", "PMC3443483", "22361852"]}, {"Citation": "Morgan G. J., Walker B. A., Davies F. E. (2012). The genetic architecture of multiple myeloma. Nat. Rev. Cancer 12:335. 10.1038/nrc3257", "ArticleIdList": ["10.1038/nrc3257", "22495321"]}, {"Citation": "Mori F., Nishie M., Piao Y. S., Kito K., Kamitani T., Takahashi H., et al. . (2005). Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol. Appl. Neurobiol. 31, 53\u201361. 10.1111/j.1365-2990.2004.00603.x", "ArticleIdList": ["10.1111/j.1365-2990.2004.00603.x", "15634231"]}, {"Citation": "Moussa C., Hebron M., Huang X., Ahn J., Rissman R. A., Aisen P. S., et al. . (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J. Neuroinflamm. 14:1. 10.1186/s12974-016-0779-0", "ArticleIdList": ["10.1186/s12974-016-0779-0", "PMC5234138", "28086917"]}, {"Citation": "Mullally J., Fitzpatrick F. (2002). Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. Mol. Pharmacol. 62, 351\u2013358. 10.1124/mol.62.2.351", "ArticleIdList": ["10.1124/mol.62.2.351", "12130688"]}, {"Citation": "Murakami A. (2013). Modulation of protein quality control systems by food phytochemicals. J. Clin. Biochem. Nutr. 52, 215\u2013227. 10.3164/jcbn.12-126", "ArticleIdList": ["10.3164/jcbn.12-126", "PMC3652296", "23704811"]}, {"Citation": "Nabavi S. F., Atanasov A. G., Khan H., Barreca D., Trombetta D., Testai L., et al. . (2018a). Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: lessons learned from clinical trials. Cancer Lett. 434, 101\u2013113. 10.1016/j.canlet.2018.07.018", "ArticleIdList": ["10.1016/j.canlet.2018.07.018", "30030139"]}, {"Citation": "Nabavi S. F., Daglia M., D'Antona G., Sobarzo-Sanchez E., Talas Z. S., Nabavi S. M. (2015). Natural compounds used as therapies targeting to amyotrophic lateral sclerosis. Curr. Pharm. Biotechnol. 16, 211\u2013218. 10.2174/1389201016666150118132224", "ArticleIdList": ["10.2174/1389201016666150118132224", "25601606"]}, {"Citation": "Nabavi S. F., Sureda A., Dehpour A. R., Shirooie S., Silva A. S., Devi K. P., et al. . (2018b). Regulation of autophagy by polyphenols: paving the road for treatment of neurodegeneration. Biotechnol. Adv. 36, 1768\u20131778. 10.1016/j.biotechadv.2017.12.001", "ArticleIdList": ["10.1016/j.biotechadv.2017.12.001", "29221764"]}, {"Citation": "Nam S., Smith D. M., Dou Q. P. (2001). Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276, 13322\u201313330. 10.1074/jbc.M004209200", "ArticleIdList": ["10.1074/jbc.M004209200", "11278274"]}, {"Citation": "N'Diaye E.-N., Debnath J., Brown E. J. (2009). Ubiquilins accelerate autophagosome maturation and promote cell survival during nutrient starvation. Autophagy 5, 573\u2013575. 10.4161/auto.5.4.8312", "ArticleIdList": ["10.4161/auto.5.4.8312", "19398896"]}, {"Citation": "Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., et al. . (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133. 10.1126/science.1134108", "ArticleIdList": ["10.1126/science.1134108", "17023659"]}, {"Citation": "Nicholson B., Marblestone J. G., Butt T. R., Mattern M. R. (2007). Deubiquitinating enzymes as novel anticancer targets. Future Oncol. 3, 191\u2013199. 10.2217/14796694.3.2.191", "ArticleIdList": ["10.2217/14796694.3.2.191", "PMC2291548", "17381419"]}, {"Citation": "Nural H., He P., Beach T., Sue L., Xia W., Shen Y. (2009). Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients. Mol. Neurodegener. 4:23. 10.1186/1750-1326-4-23", "ArticleIdList": ["10.1186/1750-1326-4-23", "PMC2704189", "19497122"]}, {"Citation": "Obeng E. A., Carlson L. M., Gutman D. M., Harrington W. J., Lee K. P., Boise L. H. (2006). Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107, 4907\u20134916. 10.1182/blood-2005-08-3531", "ArticleIdList": ["10.1182/blood-2005-08-3531", "PMC1895817", "16507771"]}, {"Citation": "Oddo S. (2008). The ubiquitin-proteasome system in Alzheimer's disease. J. Cell Mol. Med. 12, 363\u2013373. 10.1111/j.1582-4934.2008.00276.x", "ArticleIdList": ["10.1111/j.1582-4934.2008.00276.x", "PMC3822529", "18266959"]}, {"Citation": "Oddo S., Caccamo A., Tran L., Lambert M. P., Glabe C. G., Klein W. L., et al. . (2006). Temporal profile of amyloid-\u03b2 (A\u03b2) oligomerization in an in vivo model of Alzheimer disease a link between A\u03b2 and tau pathology. J. Biol. Chem. 281, 1599\u20131604. 10.1074/jbc.M507892200", "ArticleIdList": ["10.1074/jbc.M507892200", "16282321"]}, {"Citation": "Okamoto K., Hirai S., Yamazaki T., Sun X., Nakazato Y. (1991). New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 129, 233\u2013236. 10.1016/0304-3940(91)90469-a", "ArticleIdList": ["10.1016/0304-3940(91)90469-a", "1660578"]}, {"Citation": "Olzmann J. A., Li L., Chin L. S. (2008). Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr. Med. Chem. 15, 47\u201360. 10.2174/092986708783330692", "ArticleIdList": ["10.2174/092986708783330692", "PMC4403008", "18220762"]}, {"Citation": "Orhan I., Daglia M., Nabavi S., Loizzo M., Sobarzo-Sanchez E., Nabavi S. (2015). Flavonoids and dementia: an update. Curr. Med. Chem. 22, 1004\u20131015. 10.2174/0929867322666141212122352", "ArticleIdList": ["10.2174/0929867322666141212122352", "25515512"]}, {"Citation": "Orlowski M., Wilk S. (2000). Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch. Biochem. Biophys. 383, 1\u201316. 10.1006/abbi.2000.2036", "ArticleIdList": ["10.1006/abbi.2000.2036", "11097171"]}, {"Citation": "Pandareesh M., Mythri R., Bharath M. S. (2015). Bioavailability of dietary polyphenols: factors contributing to their clinical application in CNS diseases. Neurochem. Int. 89, 198\u2013208. 10.1016/j.neuint.2015.07.003", "ArticleIdList": ["10.1016/j.neuint.2015.07.003", "26163045"]}, {"Citation": "Pe\u00f1a-Altamira E., Petralla S., Massenzio F., Virgili M., Bolognesi M. L., Monti B. (2017). Nutritional and pharmacological strategies to regulate microglial polarization in cognitive aging and Alzheimer's disease. Front. Aging Neurosci. 9:175. 10.3389/fnagi.2017.00175", "ArticleIdList": ["10.3389/fnagi.2017.00175", "PMC5461295", "28638339"]}, {"Citation": "Poon W. W., Carlos A. J., Aguilar B. L., Berchtold N. C., Kawano C. K., Zograbyan V., et al. . (2013). \u03b2-Amyloid (A\u03b2) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1. J. Biol. Chem. 288, 16937\u201316948. 10.1074/jbc.M113.463711", "ArticleIdList": ["10.1074/jbc.M113.463711", "PMC3675626", "23599427"]}, {"Citation": "Popovic D., Vucic D., Dikic I. (2014). Ubiquitination in disease pathogenesis and treatment. Nat. Med. 20:1242. 10.1038/nm.3739", "ArticleIdList": ["10.1038/nm.3739", "25375928"]}, {"Citation": "Querfurth H. W., LaFerla F. M. (2010). Alzheimer's disease. N. Engl. J. Med. 362, 329\u2013344. 10.1056/NEJMra0909142", "ArticleIdList": ["10.1056/NEJMra0909142", "20107219"]}, {"Citation": "Rahman I., Chung S. (2010). Dietary polyphenols, deacetylases and chromatin remodeling in resveratrol and other polyphenols on the most common brain age-related diseases. Curr. Med. Chem. 24, 4245\u20134266. 10.1159/000314513", "ArticleIdList": ["10.1159/000314513", "28738770"]}, {"Citation": "Rao G., Croft B., Teng C., Awasthi V. (2015). Ubiquitin-proteasome system in neurodegenerative disorders. J. Drug Metab. Toxicol. 6:187. 10.4172/2157-7609.1000187", "ArticleIdList": ["10.4172/2157-7609.1000187", "PMC6370320", "30761219"]}, {"Citation": "Renton A. E., Majounie E., Waite A., Sim\u00f3n-S\u00e1nchez J., Rollinson S., Gibbs J. R., et al. . (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257\u2013268. 10.1016/j.neuron.2011.09.010", "ArticleIdList": ["10.1016/j.neuron.2011.09.010", "PMC3200438", "21944779"]}, {"Citation": "Reyes-Turcu F. E., Ventii K. H., Wilkinson K. D. (2009). Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Ann. Rev. Biochem. 78, 363\u2013397. 10.1146/annurev.biochem.78.082307.091526", "ArticleIdList": ["10.1146/annurev.biochem.78.082307.091526", "PMC2734102", "19489724"]}, {"Citation": "Richardson P. G., Hideshima T., Anderson K. C. (2003). Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers. Cancer Control 10, 361\u2013369. 10.1177/107327480301000502", "ArticleIdList": ["10.1177/107327480301000502", "14581890"]}, {"Citation": "Ringman J. M., Frautschy S. A., Teng E., Begum A. N., Bardens J., Beigi M., et al. . (2012). Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res. Ther. 4:43. 10.1186/alzrt146", "ArticleIdList": ["10.1186/alzrt146", "PMC3580400", "23107780"]}, {"Citation": "Rivett A. J., Hearn A. R. (2004). Proteasome function in antigen presentation: immunoproteasome complexes, peptide production, and interactions with viral proteins. Curr. Protein Pept. Sci. 5, 153\u2013161. 10.2174/1389203043379774", "ArticleIdList": ["10.2174/1389203043379774", "15180520"]}, {"Citation": "Rock K. L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., et al. . (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761\u2013771. 10.1016/s0092-8674(94)90462-6", "ArticleIdList": ["10.1016/s0092-8674(94)90462-6", "8087844"]}, {"Citation": "Rock K. L., York I. A., Saric T., Goldberg A. L. (2002). Protein degradation and the generation of MHC class I-presented peptides Adv. Immunol. 80, 1\u201370. 10.1016/S0065-2776(02)80012-8", "ArticleIdList": ["10.1016/S0065-2776(02)80012-8", "12078479"]}, {"Citation": "Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., et al. . (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59. 10.1038/362059a0", "ArticleIdList": ["10.1038/362059a0", "8446170"]}, {"Citation": "Russo S. M., Tepper J. E., Baldwin A. S., Jr., Liu R., Adams J., Elliott P., et al. . (2001). Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-\u03baB. Int. J. Radiat. Oncol. Biol. Phys. 50, 183\u2013193. 10.1016/s0360-3016(01)01446-8", "ArticleIdList": ["10.1016/s0360-3016(01)01446-8", "11316563"]}, {"Citation": "Safren N., Chang L., Dziki K. M., Monteiro M. J. (2015). Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington's disease. Brain Res. 1597, 37\u201346. 10.1016/j.brainres.2014.12.008", "ArticleIdList": ["10.1016/j.brainres.2014.12.008", "PMC4340744", "25511991"]}, {"Citation": "Salminen A., Kaarniranta K., Haapasalo A., Hiltunen M., Soininen H., Alafuzoff I. (2012). Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease. Prog. Neurobiol. 96, 87\u201395. 10.1016/j.pneurobio.2011.11.005", "ArticleIdList": ["10.1016/j.pneurobio.2011.11.005", "22138392"]}, {"Citation": "Sanadgol N., Zahedani S. S., Sharifzadeh M., Khalseh R., Barbari G. R., Abdollahi M. (2017). Recent updates in imperative natural compounds for healthy brain and nerve function: a systematic review of implications for multiple sclerosis. Curr. Drug Targets 18, 1499\u20131517. 10.2174/1389450118666161108124414", "ArticleIdList": ["10.2174/1389450118666161108124414", "27829351"]}, {"Citation": "Sang Y., Yan F., Ren X. (2015). The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications. Oncotarget 6, 42590\u201342602. 10.18632/oncotarget.6052", "ArticleIdList": ["10.18632/oncotarget.6052", "PMC4767455", "26460955"]}, {"Citation": "Sarubbo F., Moranta D., Asensio V. J., Miralles A., Esteban S. (2017). Effects of resveratrol and other polyphenols on the most common brain age-related diseases. Curr. Med. Chem. 24, 4245\u20134266. 10.2174/0929867324666170724102743", "ArticleIdList": ["10.2174/0929867324666170724102743", "28738770"]}, {"Citation": "Saurin A. J., Borden K. L., Boddy M. N., Freemont P. S. (1996). Does this have a familiar RING? Trends Biochem. Sci. 21, 208\u2013214. 10.1016/S0968-0004(96)80017-X", "ArticleIdList": ["10.1016/S0968-0004(96)80017-X", "8744354"]}, {"Citation": "Scherer D. C., Brockman J. A., Bendall H. H., Zhang G. M., Ballard D. W., Oltz E. M. (1996). Corepression of RelA and c-Rel inhibits immunoglobulin \u03ba gene transcription and rearrangement in precursor B lymphocytes. Immunity 5, 563\u2013574. 10.1016/s1074-7613(00)80271-x", "ArticleIdList": ["10.1016/s1074-7613(00)80271-x", "8986716"]}, {"Citation": "Sciammas R., Shaffer A., Schatz J. H., Zhao H., Staudt L. M., Singh H. (2006). Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25, 225\u2013236. 10.1016/j.immuni.2006.07.009", "ArticleIdList": ["10.1016/j.immuni.2006.07.009", "16919487"]}, {"Citation": "Selkoe D. J. (2002). Alzheimer's disease is a synaptic failure. Science 298, 789\u2013791. 10.1126/science.1074069", "ArticleIdList": ["10.1126/science.1074069", "12399581"]}, {"Citation": "Seo H., Isacson O. (2010). The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome. J. Neurochem. 114, 1819\u20131826. 10.1111/j.1471-4159.2010.06902.x", "ArticleIdList": ["10.1111/j.1471-4159.2010.06902.x", "20698932"]}, {"Citation": "Setsuie R., Wada K. (2007). The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int. 51, 105\u2013111. 10.1016/j.neuint.2007.05.007", "ArticleIdList": ["10.1016/j.neuint.2007.05.007", "17586089"]}, {"Citation": "Shaffer A. L., Emre N. C., Lamy L., Ngo V. N., Wright G., Xiao W., et al. . (2008). IRF4 addiction in multiple myeloma. Nature 454, 226\u2013231. 10.1038/nature07064", "ArticleIdList": ["10.1038/nature07064", "PMC2542904", "18568025"]}, {"Citation": "Shinbo Y., Niki T., Taira T., Ooe H., Takahashi-Niki K., Maita C., et al. . (2006). Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ. 13, 96\u2013108. 10.1038/sj.cdd.4401704", "ArticleIdList": ["10.1038/sj.cdd.4401704", "15976810"]}, {"Citation": "Shinji S., Naito Z., Ishiwata S., Ishiwata T., Tanaka N., Furukawa K., et al. . (2006). Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol. Rep. 15, 539\u2013543. 10.3892/or.15.3.539", "ArticleIdList": ["10.3892/or.15.3.539", "16465409"]}, {"Citation": "Si X., Wang Y., Wong J., Zhang J., McManus B. M., Luo H. (2007). Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J. Virol. 81, 3142\u20133150. 10.1128/JVI.02028-06", "ArticleIdList": ["10.1128/JVI.02028-06", "PMC1866032", "17229707"]}, {"Citation": "Smith D. M., Wang Z., Kazi A., Li L.-H., Chan T.-H., Dou Q. P. (2002). Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol. Med. 8:382. 10.1007/BF03402019", "ArticleIdList": ["10.1007/BF03402019", "PMC2040000", "12393936"]}, {"Citation": "Snyder H., Mensah K., Theisler C., Lee J. M., Matouschek A., Wolozin B. (2003). Aggregated and monomeric alpha-synuclein bind to the S6'proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 278, 11753\u201311759. 10.1074/jbc.M208641200", "ArticleIdList": ["10.1074/jbc.M208641200", "12551928"]}, {"Citation": "Song M., Song S., Kim S., Nakayama K., Nakayama K., Lim D.-S. (2008). Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G 1\u2013S transition. Oncogene 27:3176 10.1038/sj.onc.1210971", "ArticleIdList": ["10.1038/sj.onc.1210971", "18071316"]}, {"Citation": "Song Y. J. C., Halliday G. M., Holton J. L., Lashley T., O'sullivan S. S., McCann H., et al. . (2009). Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J. Neuropathol. Exp. Neurol. 68, 1073\u20131083. 10.1097/NEN.0b013e3181b66f1b", "ArticleIdList": ["10.1097/NEN.0b013e3181b66f1b", "19918119"]}, {"Citation": "Srivastava P., Dhuriya Y. K., Kumar V., Srivastava A., Gupta R., Shukla R. K., et al. . (2018). PI3K/Akt/GSK3\u03b2 induced CREB activation ameliorates arsenic mediated alterations in NMDA receptors and associated signaling in rat hippocampus: neuroprotective role of curcumin. Neurotoxicology 67, 190\u2013205. 10.1016/j.neuro.2018.04.018", "ArticleIdList": ["10.1016/j.neuro.2018.04.018", "29723552"]}, {"Citation": "Stieren E. S., El Ayadi A., Xiao Y., Siller E., Landsverk M. L., Oberhauser A. F., et al. . (2011). Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein. J. Biol. Chem. 286, 35689\u201335698. 10.1074/jbc.M111.243147", "ArticleIdList": ["10.1074/jbc.M111.243147", "PMC3195644", "21852239"]}, {"Citation": "Stolz A., Dikic I. (2018). Heterotypic ubiquitin chains: seeing is believing. Trends Cell Biol. 28, 1\u20133. 10.1016/j.tcb.2017.11.005", "ArticleIdList": ["10.1016/j.tcb.2017.11.005", "29191367"]}, {"Citation": "Strathearn K. E., Yousef G. G., Grace M. H., Roy S. L., Tambe M. A., Ferruzzi M. G., et al. (2014). Neuroprotective effects of anthocyanin-and proanthocyanidin-rich extracts in cellular models of Parkinson? s disease. Brain Res. 1555, 60\u201377. 10.1016/j.brainres.2014.01.047", "ArticleIdList": ["10.1016/j.brainres.2014.01.047", "PMC4024464", "24502982"]}, {"Citation": "Sundaram R. S., Gowtham L. (2012). Microglia and regulation of inflammation-mediated neurodegeneration: prevention and treatment by phytochemicals and metabolic nutrients. Int. J. Green Pharm. 6, 81\u201392. 10.4103/0973-8258.102807", "ArticleIdList": ["10.4103/0973-8258.102807"]}, {"Citation": "Sunwoo J. B., Chen Z., Dong G., Yeh N., Bancroft C. C., Sausville E., et al. (2001). Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-\u03baB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res. 7, 1419\u20131428.", "ArticleIdList": ["11350913"]}, {"Citation": "Tai H.-C., Serrano-Pozo A., Hashimoto T., Frosch M. P., Spires-Jones T. L., Hyman B. T. (2012). The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am. J. Pathol. 181, 1426\u20131435. 10.1016/j.ajpath.2012.06.033", "ArticleIdList": ["10.1016/j.ajpath.2012.06.033", "PMC3463637", "22867711"]}, {"Citation": "Tambe M. A. (2015). Neuroprotective effects of polyphenols in cellular models of Parkinson's disease. Brain Res. 1555, 60\u201377. 10.1016/j.brainres.2015.01.047", "ArticleIdList": ["10.1016/j.brainres.2015.01.047", "PMC4024464", "24502982"]}, {"Citation": "Tan S. H., Karri V., Tay N. W. R., Chang K. H., Ah H. Y., Ng P. Q., et al. . (2019). Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease. Biomed. Pharmacother. 111, 765\u2013777. 10.1016/j.biopha.2018.12.101", "ArticleIdList": ["10.1016/j.biopha.2018.12.101", "30612001"]}, {"Citation": "Tanaka K., Suzuki T., Chiba T. (1998). The ligation systems for ubiquitin and ubiquitin-like proteins. Mol. Cells 8, 503\u2013512.", "ArticleIdList": ["9856335"]}, {"Citation": "Tanaka Y., Engelender S., Igarashi S., Rao R. K., Wanner T., Tanzi R. E., et al. . (2001). Inducible expression of mutant \u03b1-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10, 919\u2013926. 10.1093/hmg/10.9.919", "ArticleIdList": ["10.1093/hmg/10.9.919", "11309365"]}, {"Citation": "Tashiro Y., Urushitani M., Inoue H., Koike M., Uchiyama Y., Komatsu M., et al. (2012). Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J. Biol. Chem. 112:417600 10.1074/jbc.M112.417600", "ArticleIdList": ["10.1074/jbc.M112.417600", "PMC3522293", "23095749"]}, {"Citation": "Tian Z., D'Arcy P., Wang X., Ray A., Tai Y.-T., Hu Y., et al. . (2013). A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. Blood 123, 706\u2013716. 10.1182/blood-2013-05-500033", "ArticleIdList": ["10.1182/blood-2013-05-500033", "PMC3907756", "24319254"]}, {"Citation": "Todi S. V., Winborn B. J., Scaglione K. M., Blount J. R., Travis S. M., Paulson H. L. (2009). Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO. J. 28, 372\u2013382. 10.1038/emboj.2008.289", "ArticleIdList": ["10.1038/emboj.2008.289", "PMC2646149", "19153604"]}, {"Citation": "Tosukhowong P., Boonla C., Dissayabutra T., Kaewwilai L., Muensri S., Chotipanich C., et al. . (2016). Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: a pilot study. J. Neurol. Sci. 367, 162\u2013170. 10.1016/j.jns.2016.05.056", "ArticleIdList": ["10.1016/j.jns.2016.05.056", "27423583"]}, {"Citation": "Tseng B. P., Green K. N., Chan J. L., Blurton-Jones M., LaFerla F. M. (2008). A\u03b2 inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging 29, 1607\u20131618. 10.1016/j.neurobiolaging.2007.04.014", "ArticleIdList": ["10.1016/j.neurobiolaging.2007.04.014", "PMC2664168", "17544172"]}, {"Citation": "Tsvetkov L. M., Yeh K.-H., Lee S.-J., Sun H., Zhang H. (1999). p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661\u2013S662. 10.1016/S0960-9822(99)80290-5", "ArticleIdList": ["10.1016/S0960-9822(99)80290-5", "10375532"]}, {"Citation": "Turner R. S., Thomas R. G., Craft S., van Dyck C. H., Mintzer J., Reynolds B. A., et al. . (2015). A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85, 1383\u20131391. 10.1212/WNL.0000000000002035", "ArticleIdList": ["10.1212/WNL.0000000000002035", "PMC4626244", "26362286"]}, {"Citation": "Urushitani M., Kurisu J., Tsukita K., Takahashi R. (2002). Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 83, 1030\u20131042. 10.1046/j.1471-4159.2002.01211.x", "ArticleIdList": ["10.1046/j.1471-4159.2002.01211.x", "12437574"]}, {"Citation": "Valenti D., de Bari L., de Rasmo D., Signorile A., Henrion-Caude A., Contestabile A., et al. . (2016). The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a down syndrome mouse model. Biochim. Biophys. Acta 1862, 1093\u20131104. 10.1016/j.bbadis.2016.03.003", "ArticleIdList": ["10.1016/j.bbadis.2016.03.003", "26964795"]}, {"Citation": "Van Deerlin V. M., Leverenz J. B., Bekris L. M., Bird T. D., Yuan W., Elman L. B., et al. . (2008). TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7, 409\u2013416. 10.1016/S1474-4422(08)70071-1", "ArticleIdList": ["10.1016/S1474-4422(08)70071-1", "PMC3546119", "18396105"]}, {"Citation": "van Horssen J., Drexhage J. A., Flor T., Gerritsen W., van der Valk P., de Vries H. E. (2010). Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic. Biol. Med. 49, 1283\u20131289. 10.1016/j.freeradbiomed.2010.07.013", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.07.013", "20673799"]}, {"Citation": "Vance C., Rogelj B., Hortob\u00e1gyi T., De Vos K. J., Nishimura A. L., Sreedharan J., et al. . (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208\u20131211. 10.1126/science.1165942", "ArticleIdList": ["10.1126/science.1165942", "PMC4516382", "19251628"]}, {"Citation": "Von Der Lehr N., Johansson S., Wu S., Bahram F., Castell A., Cetinkaya C., et al. . (2003). The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol. Cell 11, 1189\u20131200. 10.1016/s1097-2765(03)00193-x", "ArticleIdList": ["10.1016/s1097-2765(03)00193-x", "12769844"]}, {"Citation": "Wagner S., Carpentier I., Rogov V., Kreike M., Ikeda F., L\u00f6hr F., et al. . (2008). Ubiquitin binding mediates the NF-\u03baB inhibitory potential of ABIN proteins. Oncogene 27:3739. 10.1038/sj.onc.1211042", "ArticleIdList": ["10.1038/sj.onc.1211042", "18212736"]}, {"Citation": "Wang C., Shou Y., Pan J., Du Y., Liu C., Wang H. (2018). The relationship between cholesterol level and Alzheimer's disease-associated APP proteolysis/Abeta metabolism. Nutr. Neurosci. 22, 453\u2013463. 10.1080/1028415X.2017.1416942", "ArticleIdList": ["10.1080/1028415X.2017.1416942", "29325505"]}, {"Citation": "Wang H.-Y., Wang I.-F., Bose J., Shen C.-K. J. (2004). Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83, 130\u2013139. 10.1016/s0888-7543(03)00214-3", "ArticleIdList": ["10.1016/s0888-7543(03)00214-3", "14667816"]}, {"Citation": "Wang R., Ying Z., Zhao J., Zhang Y., Wang R., Lu H., et al. (2012). Lys203 and Lys382 are essential for the proteasomal degradation of BACE1. Curr. Alzheimer Res. 9, 606\u2013615. 10.2174/156720512800618026", "ArticleIdList": ["10.2174/156720512800618026", "22299711"]}, {"Citation": "Wang X., Mazurkiewicz M., Hillert E.-K., Olofsson M. H., Pierrou S., Hillertz P., et al. (2016). The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells. Sci. Rep. 6:26979 10.1038/srep26979", "ArticleIdList": ["10.1038/srep26979", "PMC4893612", "27264969"]}, {"Citation": "Wang Y., Garg S., Mandelkow E.-M., Mandelkow E. (2010). Proteolytic processing of tau. Biochem.ss Soc. Trans. 38, 955\u2013961. 10.1042/BST0380955", "ArticleIdList": ["10.1042/BST0380955", "20658984"]}, {"Citation": "Waring S. C., Rosenberg R. N. (2008). Genome-wide association studies in Alzheimer disease. Arch. Neurol. 65, 329\u2013334. 10.1001/archneur.65.3.329", "ArticleIdList": ["10.1001/archneur.65.3.329", "18332245"]}, {"Citation": "Wickner S., Maurizi M. R., Gottesman S. (1999). Posttranslational quality control: folding, refolding, and degrading proteins. Science 286, 1888\u20131893. 10.1126/science.286.5446.1888", "ArticleIdList": ["10.1126/science.286.5446.1888", "10583944"]}, {"Citation": "Wicks S. J., Haros K., Maillard M., Song L., Cohen R. E., ten Dijke P., et al. . (2005). The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-\u03b2 signalling. Oncogene 24:8080. 10.1038/sj.onc.1208944", "ArticleIdList": ["10.1038/sj.onc.1208944", "16027725"]}, {"Citation": "William C. S., Liou H.-C., Tuomanen E. I., Baltimore D. (1995). Targeted disruption of the p50 subunit of NF-\u03baB leads to multifocal defects in immune responses. Cell 80, 321\u2013330. 10.1016/0092-8674(95)90415-8", "ArticleIdList": ["10.1016/0092-8674(95)90415-8", "7834752"]}, {"Citation": "Williams K. L., Topp S., Yang S., Smith B., Fifita J. A., Warraich S. T., et al. . (2016). CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat. Commun. 7:11253. 10.1038/ncomms11253", "ArticleIdList": ["10.1038/ncomms11253", "PMC4835537", "27080313"]}, {"Citation": "Winklhofer K. F., Haass C. (2010). Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 1802, 29\u201344. 10.1016/j.bbadis.2009.08.013", "ArticleIdList": ["10.1016/j.bbadis.2009.08.013", "19733240"]}, {"Citation": "Wu M., Lee H., Bellas R. E., Schauer S. L., Arsura M., Katz D., et al. . (1996). Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 15, 4682\u20134690. 10.1002/j.1460-2075.1996.tb00845.x", "ArticleIdList": ["10.1002/j.1460-2075.1996.tb00845.x", "PMC452200", "8887559"]}, {"Citation": "Xie H., Wu J. (2016). Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells. Chem. Biol. Interact. 258, 197\u2013204. 10.1016/j.cbi.2016.09.006", "ArticleIdList": ["10.1016/j.cbi.2016.09.006", "27613482"]}, {"Citation": "Xiong H., Wang D., Chen L., Choo Y. S., Ma H., Tang C., et al. . (2009). Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J. Clin. Invest. 119, 650\u2013660. 10.1172/JCI37617", "ArticleIdList": ["10.1172/JCI37617", "PMC2648688", "19229105"]}, {"Citation": "Xue S., Jia J. (2006). Genetic association between ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Brain Res. 1087, 28\u201332. 10.1016/j.brainres.2006.02.121", "ArticleIdList": ["10.1016/j.brainres.2006.02.121", "16626667"]}, {"Citation": "Yassa N., Masoomi F., Rohani Rankouhi S. E., Hadjiakhoondi A. (2009). Chemical composition and antioxidant activity of the extract and essential oil of Rosa damascena from Iran, population of Guilan. Daru 17, 175\u2013180."}, {"Citation": "Yin F., Ye F., Tan L., Liu K., Xuan Z., Zhang J., et al. . (2012). Alterations of signaling pathways in muscle tissues of patients with amyotrophic lateral sclerosis. Muscle Nerve 46, 856\u2013860. 10.1002/mus.23411", "ArticleIdList": ["10.1002/mus.23411", "22996383"]}, {"Citation": "Yu Z.-K., Gervais J. L., Zhang H. (1998). Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21CIP1/WAF1 and cyclin D proteins. Proc. Natl. Acad. Sci. U.S.A. 95, 11324\u201311329. 10.1073/pnas.95.19.11324", "ArticleIdList": ["10.1073/pnas.95.19.11324", "PMC21641", "9736735"]}, {"Citation": "Zaffagnini G., Savova A., Danieli A., Romanov J., Tremel S., Ebner M. (2018). Phasing out the bad-How SQSTM1/p62 sequesters ubiquitinated proteins for degradation by autophagy. Autophagy 14, 1280\u20131282. 10.1080/15548627.2018.1462079", "ArticleIdList": ["10.1080/15548627.2018.1462079", "PMC6103668", "29929426"]}, {"Citation": "Zeng X. S., Geng W. S., Jia J. J., Chen L., Zhang P. P. (2018). Cellular and molecular basis of neurodegeneration in parkinson disease. Front. Aging Neurosci. 10:109. 10.3389/fnagi.2018.00109", "ArticleIdList": ["10.3389/fnagi.2018.00109", "PMC5913322", "29719505"]}, {"Citation": "Zhan F., Colla S., Wu X., Chen B., Stewart J. P., Kuehl W. M., et al. . (2007). CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2-and p27Kip1-dependent and-independent mechanisms. Blood 109, 4995\u20135001. 10.1182/blood-2006-07-038703", "ArticleIdList": ["10.1182/blood-2006-07-038703", "PMC1885527", "17303695"]}, {"Citation": "Zhang M., Deng Y., Luo Y., Zhang S., Zou H., Cai F., et al. . (2012). Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. J. Neurochem. 120, 1129\u20131138. 10.1111/j.1471-4159.2011.07644.x", "ArticleIdList": ["10.1111/j.1471-4159.2011.07644.x", "22212137"]}, {"Citation": "Zhang N.-Y., Tang Z., Liu C.-W. (2008). \u03b1-synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation understanding the cytotoxicity of protein pathogenesis. J. Biol. Chem. 283, 20288\u201320298. 10.1074/jbc.M710560200", "ArticleIdList": ["10.1074/jbc.M710560200", "18502751"]}, {"Citation": "Zheng C., Geetha T., Babu J. R. (2014). Failure of ubiquitin proteasome system: risk for neurodegenerative diseases. Neurodegener. Dis. 14, 161\u2013175. 10.1159/000367694", "ArticleIdList": ["10.1159/000367694", "25413678"]}, {"Citation": "Zheng Q., Huang T., Zhang L., Zhou Y., Luo H., Xu H., et al. . (2016). Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases. Front. Aging Neurosci. 8:303. 10.3389/fnagi.2016.00303", "ArticleIdList": ["10.3389/fnagi.2016.00303", "PMC5156861", "28018215"]}, {"Citation": "Zhu C. W., Grossman H., Neugroschl J., Parker S., Burden A., Luo X., et al. . (2018). A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: a pilot study. Alzheimers Dement. 4, 609\u2013616. 10.1016/j.trci.2018.09.009", "ArticleIdList": ["10.1016/j.trci.2018.09.009", "PMC6240843", "30480082"]}, {"Citation": "Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R. T., Remotti H., et al. . (1998). CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12, 982\u2013995. 10.1101/gad.12.7.982", "ArticleIdList": ["10.1101/gad.12.7.982", "PMC316680", "9531536"]}, {"Citation": "Zucchelli S., Marcuzzi F., Codrich M., Agostoni E., Vilotti S., Biagioli M., et al. (2011). Tumor Necrosis factor receptor associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation. J. Biol. Chem. 110:187591 10.1074/jbc.M110.187591", "ArticleIdList": ["10.1074/jbc.M110.187591", "PMC3137084", "21454471"]}]}], "History": [{"Year": "2019", "Month": "8", "Day": "20"}, {"Year": "2020", "Month": "3", "Day": "27"}, {"Year": "2020", "Month": "5", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "16", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "4", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["32411012", "PMC7199656", "10.3389/fphys.2020.00361"]}}]}